Cargando…
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV–infected mice
Pathogenic coronaviruses are a major threat to global public health, as exemplified by severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and the newly emerged SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19). We d...
Autores principales: | Rathnayake, Athri D., Zheng, Jian, Kim, Yunjeong, Perera, Krishani Dinali, Mackin, Samantha, Meyerholz, David K., Kashipathy, Maithri M., Battaile, Kevin P., Lovell, Scott, Perlman, Stanley, Groutas, William C., Chang, Kyeong-Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574915/ https://www.ncbi.nlm.nih.gov/pubmed/32747425 http://dx.doi.org/10.1126/scitranslmed.abc5332 |
Ejemplares similares
-
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
por: Dampalla, Chamandi S., et al.
Publicado: (2021) -
Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor
por: Perera, Krishani Dinali, et al.
Publicado: (2019) -
Protease inhibitors broadly effective against feline, ferret and mink coronaviruses
por: Perera, Krishani Dinali, et al.
Publicado: (2018) -
Potent Protease Inhibitors of Highly Pathogenic Lagoviruses: Rabbit Hemorrhagic Disease Virus and European Brown Hare Syndrome Virus
por: Perera, Krishani Dinali, et al.
Publicado: (2022) -
Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
por: Chang, Kyeong-Ok, et al.
Publicado: (2019)